<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Vulvovaginal Candidiasis â€” Quick Reference</title>
  <meta name="description" content="One-page clinical algorithm for fast decision-making in vulvovaginal candidiasis (VVC)." />
  <style>
    /* ---------- CSS RESET (trimmed) ---------- */
    *,*::before,*::after{box-sizing:border-box}
    html,body{margin:0;padding:0}
    img,svg{display:block;max-width:100%}
    button{font:inherit}

    /* ---------- THEME ---------- */
    :root{
      --bg:#0b1020;
      --bg-elev:#111833;
      --panel:#0f1530;
      --text:#eef2ff;
      --muted:#c1c7dc;
      --brand:#7aa2ff;
      --brand-2:#55e6c1;
      --accent:#f8d57e;
      --card:#121a3a;
      --border:rgba(255,255,255,.08);
      --ok:#55e6c1; --warn:#ffd166; --bad:#ff6b6b;
      --shadow:0 8px 24px rgba(0,0,0,.35), 0 2px 6px rgba(0,0,0,.2);
      --radius:18px;
      --radius-sm:12px;
      --maxw:1100px;
    }
    [data-theme="light"]{
      --bg:#f7f8fc;
      --bg-elev:#ffffff;
      --panel:#ffffff;
      --text:#101327;
      --muted:#4b5168;
      --brand:#2b6fff;
      --brand-2:#03b286;
      --accent:#946200;
      --card:#ffffff;
      --border:rgba(16,19,39,.1);
      --shadow:0 10px 30px rgba(16,19,39,.08), 0 2px 8px rgba(16,19,39,.06);
    }

    body{
      font-family: ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      background: radial-gradient(1200px 600px at 80% -10%, rgba(122,162,255,.15), transparent),
                  radial-gradient(1000px 500px at -10% 20%, rgba(85,230,193,.12), transparent),
                  var(--bg);
      color:var(--text);
      line-height:1.55;
    }

    .wrap{max-width:var(--maxw); margin:0 auto; padding:28px 20px 64px;}

    /* ---------- HEADER ---------- */
    header{
      position:sticky; top:0; z-index:10;
      backdrop-filter:saturate(1.4) blur(16px);
      background:linear-gradient(180deg, rgba(10,12,25,.7), rgba(10,12,25,.35));
      border-bottom:1px solid var(--border);
    }
    [data-theme="light"] header{background:linear-gradient(180deg, rgba(255,255,255,.85), rgba(255,255,255,.6));}

    .head{max-width:var(--maxw); margin:0 auto; padding:14px 20px; display:flex; gap:14px; align-items:center;}
    .logo{display:flex; align-items:center; gap:12px; text-decoration:none; color:var(--text)}
    .logo svg{width:28px; height:28px; filter: drop-shadow(0 6px 12px rgba(0,0,0,.25));}
    .title{font-weight:800; letter-spacing:.3px;}
    .tag{font-size:.78rem; padding:4px 8px; border:1px solid var(--border); border-radius:999px; color:var(--muted)}
    .spacer{flex:1}
    .btn{display:inline-flex; align-items:center; gap:8px; padding:10px 14px; border-radius:12px; border:1px solid var(--border); background:var(--bg-elev); color:var(--text); cursor:pointer; box-shadow:var(--shadow);}
    .btn:hover{transform:translateY(-1px)}

    /* ---------- HERO ---------- */
    .hero{display:grid; gap:18px; margin:28px 0 12px; align-items:center; grid-template-columns:1fr;}
    .heroCard{background:linear-gradient(155deg, rgba(122,162,255,.16), rgba(85,230,193,.14)); border:1px solid var(--border); border-radius:var(--radius); padding:20px; box-shadow:var(--shadow);}
    h1{font-size:clamp(1.4rem, 3.2vw, 2.1rem); margin:0 0 8px;}
    .sub{color:var(--muted)}

    /* ---------- GRID ---------- */
    .grid{display:grid; grid-template-columns: 280px 1fr; gap:24px; margin-top:24px}
    @media (max-width: 920px){ .grid{grid-template-columns:1fr} }

    /* ---------- SIDENAV ---------- */
    .side{position:sticky; top:76px; align-self:start; display:flex; flex-direction:column; gap:10px;}
    .side a{display:flex; align-items:center; gap:10px; text-decoration:none; border:1px solid var(--border); border-radius:12px; padding:10px 12px; color:var(--text); background:var(--panel);}
    .side a:hover{background:linear-gradient(155deg, rgba(122,162,255,.12), rgba(85,230,193,.10));}
    .side small{color:var(--muted)}

    /* ---------- CARDS ---------- */
    section.card{background:var(--card); border:1px solid var(--border); border-radius:var(--radius); padding:18px 18px 14px; box-shadow:var(--shadow);}
    section.card h2{font-size:1.12rem; margin:0 0 12px; display:flex; align-items:center; gap:10px;}
    .kicker{font-size:.82rem; color:var(--muted); margin-bottom:10px}

    ul{margin:0; padding-left:18px}
    li{margin:6px 0}

    .pill{display:inline-flex; align-items:center; gap:8px; padding:6px 10px; border:1px solid var(--border); border-radius:999px; background:rgba(255,255,255,.04);}
    .badge{font-size:.78rem; padding:3px 8px; border-radius:999px; border:1px solid var(--border); color:var(--muted)}

    .gridCards{display:grid; grid-template-columns:repeat(2,1fr); gap:16px}
    @media (max-width: 920px){ .gridCards{grid-template-columns:1fr} }

    .callout{border-left:4px solid var(--brand); padding:10px 12px; background:linear-gradient(90deg, rgba(122,162,255,.12), transparent); border-radius:8px;}
    .warn{border-left-color:var(--warn); background:linear-gradient(90deg, rgba(255,209,102,.15), transparent)}

    /* ---------- FOOTER ---------- */
    footer{margin-top:28px; color:var(--muted); font-size:.9rem}

    /* ---------- PRINT ---------- */
    @media print{
      @page{size:A4; margin:12mm}
      header, .side, .btn{display:none!important}
      body{background:white}
      section.card{page-break-inside:avoid}
      .grid{grid-template-columns:1fr}
    }
  </style>
</head>
<body>
  <header>
    <div class="head">
      <a class="logo" href="#top" aria-label="VVC Quick Reference Home">
        <!-- Simple cross/leaf medical brand mark -->
        <svg viewBox="0 0 48 48" aria-hidden="true" role="img">
          <defs>
            <linearGradient id="g" x1="0" x2="1" y1="0" y2="1">
              <stop offset="0" stop-color="var(--brand)"/>
              <stop offset="1" stop-color="var(--brand-2)"/>
            </linearGradient>
          </defs>
          <rect x="8" y="8" width="32" height="32" rx="9" fill="url(#g)"/>
          <path d="M24 14v20M14 24h20" stroke="var(--panel)" stroke-width="4" stroke-linecap="round"/>
        </svg>
        <div class="title">Vulvovaginal Candidiasis â€” Quick Reference</div>
      </a>
      <span class="tag">One-page algorithm</span>
      <div class="spacer"></div>
      <button class="btn" id="printBtn" title="Print or save as PDF">ğŸ–¨ï¸ Print</button>
      <button class="btn" id="modeBtn" title="Toggle light/dark">ğŸŒ™ Theme</button>
    </div>
  </header>

  <main class="wrap">
    <section class="hero">
      <div class="heroCard">
        <h1>Fast, clinic-ready aide-mÃ©moire</h1>
        <p class="sub">Condensed from detailed guidance for rapid assessment and management during patient consultations. Last revised (source) OctÂ 2023.</p>
        <div style="display:flex; flex-wrap:wrap; gap:10px; margin-top:10px">
          <span class="pill">Primary care use</span>
          <span class="pill">Age â‰¥12 (Female)</span>
          <span class="pill">UK-oriented</span>
        </div>
      </div>
    </section>

    <div class="grid">
      <!-- Side nav -->
      <nav class="side" aria-label="On-page navigation">
        <a href="#dx">ğŸ” <span>Diagnosis</span></a>
        <a href="#acute">ğŸ’Š <span>Acute VVC</span></a>
        <a href="#preg">ğŸ¤° <span>Pregnancy</span></a>
        <a href="#recur">â™»ï¸ <span>Recurrent VVC</span></a>
        <a href="#complex">ğŸ§« <span>Complicated / Nonâ€‘albicans</span></a>
        <a href="#failure">ğŸ§­ <span>Treatment failure</span></a>
        <a href="#refer">ğŸ“¨ <span>When to refer</span></a>
        <a href="#keys">âœ… <span>Key reminders</span></a>
      </nav>

      <div class="stack" style="display:flex; flex-direction:column; gap:18px">
        <!-- Diagnosis -->
        <section id="dx" class="card" aria-labelledby="dx-h">
          <div class="kicker">Assess</div>
          <h2 id="dx-h">ğŸ” Diagnosis</h2>
          <div class="gridCards">
            <div>
              <h3 class="badge">Typical features</h3>
              <ul>
                <li>Vulval/vaginal <strong>itch</strong> (defining), soreness, curdâ€‘like nonâ€‘malodorous discharge.</li>
                <li>Superficial dyspareunia; dysuria.</li>
              </ul>
            </div>
            <div>
              <h3 class="badge">Consider alternatives</h3>
              <ul>
                <li>Bacterial vaginosis, trichomoniasis, chlamydia/gonorrhoea, genital herpes.</li>
                <li>Physiological discharge, dermatitis/eczema, lichen sclerosus/planus, psoriasis, atrophic vaginitis, vulvodynia, foreign body.</li>
              </ul>
            </div>
          </div>
          <div class="callout" style="margin-top:10px">
            <strong>Investigations</strong> â€” Not required if typical & infrequent. Use swabs if recurrent, atypical, or treatment failure: HVS for microscopy; culture (with speciation Â± sensitivities) for recurrent or poor response. Consider STI screen if risks.
          </div>
        </section>

        <!-- Acute VVC -->
        <section id="acute" class="card" aria-labelledby="acute-h">
          <div class="kicker">Treat</div>
          <h2 id="acute-h">ğŸ’Š Acute VVC</h2>
          <p class="badge">Choose ONE firstâ€‘line</p>
          <ul>
            <li><strong>Fluconazole 150Â mg PO once</strong> (avoid in pregnancy; check interactions/QT risk).</li>
            <li><strong>Clotrimazole pessary 500Â mg</strong> once (or 10% cream intravaginal once).</li>
          </ul>
          <ul>
            <li>For vulval symptoms: add topical imidazole cream (clotrimazole 1â€“2%) 2â€“3Ã—/day.</li>
            <li class="callout warn" style="list-style:none; margin-top:8px"><strong>Note:</strong> Topical imidazoles may damage latex condoms/diaphragms; many options are OTC.</li>
          </ul>
          <div class="callout" style="margin-top:10px">
            <strong>Severe features</strong> (marked erythema, fissuring, oedema): repeat dose after 72Â h â€” e.g., fluconazole 150Â mg on dayÂ 1 & dayÂ 4.
          </div>
          <p style="margin-top:8px">Followâ€‘up if not resolved in <strong>7â€“14Â days</strong>. Do <em>not</em> routinely treat asymptomatic male partner.</p>
        </section>

        <!-- Pregnancy -->
        <section id="preg" class="card" aria-labelledby="preg-h">
          <div class="kicker">Special population</div>
          <h2 id="preg-h">ğŸ¤° Pregnancy</h2>
          <ul>
            <li><strong>Topical azoles only</strong>. Firstâ€‘line: clotrimazole <strong>500Â mg pessary nocte up to 7Â nights</strong> (age â‰¥16).</li>
            <li>Alternatives (if needed): clotrimazole 10% cream up to 7Â nights; miconazole 1,200Â mg or 400Â mg vaginal capsule up to 7Â nights; econazole 150Â mg up to 7Â nights; 2% miconazole cream 7Â nights.</li>
            <li><strong>Avoid oral fluconazole</strong>. For recurrent infection: 10â€“14Â days topical induction â†’ 500Â mg clotrimazole pessary weekly Ã—Â 6Â months.</li>
          </ul>
        </section>

        <!-- Recurrent VVC -->
        <section id="recur" class="card" aria-labelledby="recur-h">
          <div class="kicker">Prevent & maintain</div>
          <h2 id="recur-h">â™»ï¸ Recurrent VVC (â‰¥4/yr)</h2>
          <ul>
            <li><strong>Confirm with culture</strong>; review risk factors (recent antibiotics, irritants, diabetes, immunosuppression; avoid douching; breathable clothing).</li>
            <li><strong>Induction</strong>: fluconazole 150Â mg PO every 72Â h Ã—Â 3 doses (daysÂ 1,Â 4,Â 7) <em>or</em> topical azole 10â€“14Â days.</li>
            <li><strong>Maintenance</strong>: fluconazole 150Â mg weekly Ã—Â 6Â months; alternatives if contraindicated: clotrimazole 500Â mg pessary weekly Ã—Â 6Â months or itraconazole 50â€“100Â mg daily Ã—Â 6Â months.</li>
            <li>If symptoms recur between doses: consider increasing frequency (per clinician judgement). If poor/partial response: check concordance; repeat HVS for culture with speciationÂ Â±Â sensitivities; reconsider diagnosis.</li>
          </ul>
        </section>

        <!-- Complicated / Non-albicans -->
        <section id="complex" class="card" aria-labelledby="complex-h">
          <div class="kicker">If atypical</div>
          <h2 id="complex-h">ğŸ§« Complicated / Nonâ€‘albicans Candida</h2>
          <ul>
            <li>Obtain culture with speciation; assess for azole resistance.</li>
            <li>Use <strong>longer topical azoles (7â€“14Â days)</strong>. Seek specialist advice for <em>C. glabrata</em> or resistance.</li>
          </ul>
        </section>

        <!-- Treatment failure -->
        <section id="failure" class="card" aria-labelledby="failure-h">
          <div class="kicker">If not improving</div>
          <h2 id="failure-h">ğŸ§­ Treatment failure (no response by 7â€“14Â days)</h2>
          <ul>
            <li>Confirm correct use; note topical irritation can mimic failure.</li>
            <li>Reassess risks; examine external genitalia; take HVS (microscopy Â± culture).</li>
            <li>Treat per results; consider alternative preparation/route; reinforce selfâ€‘care.</li>
          </ul>
        </section>

        <!-- When to refer -->
        <section id="refer" class="card" aria-labelledby="refer-h">
          <div class="kicker">Escalate</div>
          <h2 id="refer-h">ğŸ“¨ When to refer / seek advice</h2>
          <ul>
            <li>Age 12â€“15 requiring treatment advice; diagnostic uncertainty.</li>
            <li>Persistent symptoms after second course; uncontrolled diabetes with failure.</li>
            <li>Nonâ€‘albicans species or suspected azole resistance; immunocompromise.</li>
          </ul>
        </section>

        <!-- Key reminders -->
        <section id="keys" class="card" aria-labelledby="keys-h">
          <div class="kicker">Remember</div>
          <h2 id="keys-h">âœ… Key reminders</h2>
          <ul>
            <li>Do not routinely treat asymptomatic male partners.</li>
            <li>Topical imidazoles may damage latex condoms/diaphragms.</li>
            <li>Fluconazole: avoid in pregnancy & breastfeeding; watch QT and interactions; halve maintenance doses in significant renal impairment (per BNF).</li>
            <li>Selfâ€‘management: emollient soap substitute; avoid irritant washes, douching, tight nonâ€‘breathable clothing; complementary therapies (e.g., yoghurt/tea tree/probiotics) not advised.</li>
          </ul>
        </section>

        <footer>
          <p>Designed for quick clinical use. Printâ€‘friendly. Source: condensed from established primaryâ€‘care guidance (OctÂ 2023). This page does not replace local formulary/BNF.</p>
        </footer>
      </div>
    </div>
  </main>

  <script>
    // Theme toggle with localStorage
    (function(){
      const root=document.documentElement;
      const saved=localStorage.getItem('vvc-theme');
      if(saved){root.setAttribute('data-theme', saved)}
      const btn=document.getElementById('modeBtn');
      btn.addEventListener('click',()=>{
        const cur=root.getAttribute('data-theme')||'dark';
        const next= cur==='light' ? 'dark' : 'light';
        root.setAttribute('data-theme', next);
        localStorage.setItem('vvc-theme', next);
        btn.textContent = next==='light' ? 'ğŸŒ™ Theme' : 'ğŸ”† Theme';
      });
      // set initial icon
      btn.textContent = (root.getAttribute('data-theme')||'dark')==='light' ? 'ğŸŒ™ Theme' : 'ğŸ”† Theme';
      // Print
      document.getElementById('printBtn').addEventListener('click', ()=> window.print());
    })();
  </script>
</body>
</html>